The company is owned primarily by the founders together with a new financial partner: Sodena, which entered the company in 2019


This company has received a grant co-financed 50% by the European Regional Development Fund through the Operative Program FEDER 2014-2020 of Navarra, for the project:“Discovery of new PPAR-gamma antagonists for the treatment of bladder cancer” (0011-1365-2018-000110)

A financial instrument of the Government of Navarra to promote business projects in the region that can contribute to the region’s development. Basically, Sodena works to try and ensure all viable projects in the self-governing region of Navarra should be able to receive financing to carry them out.

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the mentioned cookies and the acceptance of our Cookies policy.

Aviso de cookies